01515 CR MEDICAL
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 0.72X | Oper Margin | 8.3% |
|---|---|---|---|
| LT Debt/Equity | 13.6% | Net Margin | 5.7% |
| Total Debt/Equity | 25.7% | Return on Equity | 9.1% |
| Price/Book | 0.72X | Return on Assets | 4.3% |
| (HKD 3.680) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 601.81 | 284.01 | 298.08 | 511.15 | 368.06 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +111.9 | -4.7 | -41.7 | +38.9 | -15.8 |
| Earnings Per Share (HKD) | 0.476 | 0.225 | 0.236 | 0.407 | 0.293 |
| Earnings Per Share Growth (%) | +111.9 | -4.9 | -42.0 | +38.9 | -15.9 |
| Dividend Per Share (HKD) | 0.144 | 0.066 | 0.037 | 0.120 | 0.088 |
| P/E* (X) | 7.73 | 16.38 | 15.58 | 9.04 | 12.56 |
| Yield (%) | 3.90 | 1.79 | 1.01 | 3.26 | 2.40 |
| Dividend Share (%) | 30.19 | 29.39 | 15.66 | 29.48 | 30.09 |
| Book NAV (HKD) | 5.096 | 4.940 | 8.220 | 6.085 | 5.588 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 4,525 | 4,976 | -9.1 | 5,114 |
| Operating Result | 461.469 | 583.811 | -21.0 | 589.966 |
| Associates | 47.45 | 44.329 | +7.0 | 41.529 |
| Profit Before Taxation | 508.123 | 627.328 | -19.0 | 625.126 |
| Taxation | 133.875 | 115.673 | +15.7 | 138.258 |
| Profit /( Loss) After Taxation | 374.248 | 511.655 | -26.9 | 486.868 |
| Minority Interests | 34.727 | 77.706 | -55.3 | 89.191 |
| Net Profit | 339.521 | 433.949 | -21.8 | 397.677 |
| Earnings Per Share () | 0.2942 | 0.3689 | -20.2 | 0.3395 |
| Dividend Per Share () | 0.0548 | 0.0547 | +0.2 | 0.0000 |
| Announcement Date | 2025-08-26 | 2024-08-26 | NA | 2023-08-22 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
